AEM vs KOP

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

KOP presents a conflicting profile: it is fundamentally stable but lacks growth momentum. The Piotroski F-Score of 4/9 indicates a stable but non-improving financial health, while the current price ($41.46) sits almost exactly at the Graham Number ($42.65), suggesting defensive fair value. However, the significant gap between the current price and the growth-based intrinsic value ($19.18), combined with negative revenue growth (-9.30%) and bearish insider activity, suggests the stock is priced for a recovery that has not yet materialized in the data.